Rights and permissions
About this article
Cite this article
Denosumab boosts HRQOL in metastatic breast cancer. Pharmacoecon. Outcomes News 620, 8 (2011). https://doi.org/10.2165/00151234-201106200-00019
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-201106200-00019